PM | Control group | P-value | |||
implantation | (no PM – implantation) | ||||
n (234) | % | n (191) | % | ||
Myocardial infarction | 4 | 1.7 | 2 | 1.1 | ns |
Neurological disorders | 11 | 4.7 | 4 | 2.1 | ns |
Bleeding (rethoracotomy) | 22 | 9.4 | 8 | 4.1 | 0.03 |
Sternal infection | 9 | 3.8 | 3 | 1.5 | ns |
Pulmonary infection | 15 | 6.4 | 6 | 3.1 | ns |
Renal complication | 8 | 3.4 | 2 | 1.1 | ns |
In-hospital mortality | 10 | 4.2 | 2 | 1.05 | 0.046 |
PM | Control group | P-value | |||
implantation | (no PM – implantation) | ||||
n (234) | % | n (191) | % | ||
Myocardial infarction | 4 | 1.7 | 2 | 1.1 | ns |
Neurological disorders | 11 | 4.7 | 4 | 2.1 | ns |
Bleeding (rethoracotomy) | 22 | 9.4 | 8 | 4.1 | 0.03 |
Sternal infection | 9 | 3.8 | 3 | 1.5 | ns |
Pulmonary infection | 15 | 6.4 | 6 | 3.1 | ns |
Renal complication | 8 | 3.4 | 2 | 1.1 | ns |
In-hospital mortality | 10 | 4.2 | 2 | 1.05 | 0.046 |
PM, pacemaker.
PM | Control group | P-value | |||
implantation | (no PM – implantation) | ||||
n (234) | % | n (191) | % | ||
Myocardial infarction | 4 | 1.7 | 2 | 1.1 | ns |
Neurological disorders | 11 | 4.7 | 4 | 2.1 | ns |
Bleeding (rethoracotomy) | 22 | 9.4 | 8 | 4.1 | 0.03 |
Sternal infection | 9 | 3.8 | 3 | 1.5 | ns |
Pulmonary infection | 15 | 6.4 | 6 | 3.1 | ns |
Renal complication | 8 | 3.4 | 2 | 1.1 | ns |
In-hospital mortality | 10 | 4.2 | 2 | 1.05 | 0.046 |
PM | Control group | P-value | |||
implantation | (no PM – implantation) | ||||
n (234) | % | n (191) | % | ||
Myocardial infarction | 4 | 1.7 | 2 | 1.1 | ns |
Neurological disorders | 11 | 4.7 | 4 | 2.1 | ns |
Bleeding (rethoracotomy) | 22 | 9.4 | 8 | 4.1 | 0.03 |
Sternal infection | 9 | 3.8 | 3 | 1.5 | ns |
Pulmonary infection | 15 | 6.4 | 6 | 3.1 | ns |
Renal complication | 8 | 3.4 | 2 | 1.1 | ns |
In-hospital mortality | 10 | 4.2 | 2 | 1.05 | 0.046 |
PM, pacemaker.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.